These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 34169283)

  • 1. Erratum to: FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
    Sharaf R; Pavlick DC; Frampton GM; Cooper M; Jenkins J; Danziger N; Haberberger J; Alexander BM; Cloughesy T; Yong WH; Liau LM; Nghiemphu PL; Ji M; Lai A; Ramkissoon SH; Albacker LA
    Neurooncol Adv; 2021; 3(1):vdab059. PubMed ID: 34169283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. FoundationOne CDx testing accurately determines whole arm 1p19q codeletion status in gliomas.
    Sharaf R; Pavlick DC; Frampton GM; Cooper M; Jenkins J; Danziger N; Haberberger J; Alexander BM; Cloughesy T; Yong WH; Liau LM; Nghiemphu PL; Ji M; Lai A; Ramkissoon SH; Albacker LA
    Neurooncol Adv; 2021; 3(1):vdab017. PubMed ID: 33778493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anaplastic oligodendrogliomas with 1p19q codeletion have a proneural gene expression profile.
    Ducray F; Idbaih A; de Reyniès A; Bièche I; Thillet J; Mokhtari K; Lair S; Marie Y; Paris S; Vidaud M; Hoang-Xuan K; Delattre O; Delattre JY; Sanson M
    Mol Cancer; 2008 May; 7():41. PubMed ID: 18492260
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conventional Magnetic Resonance Features for Predicting 1p19q Codeletion Status of World Health Organization Grade II and III Diffuse Gliomas.
    Peng X; Yishuang C; Kaizhou Z; Xiao L; Ma C
    J Comput Assist Tomogr; 2019; 43(2):269-276. PubMed ID: 30371623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system.
    Figarella-Branger D; Bouvier C; de Paula AM; Mokhtari K; Colin C; Loundou A; Chinot O; Metellus P
    J Neurooncol; 2012 Nov; 110(2):205-13. PubMed ID: 22890969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of alpha internexin expression in a series of 409 gliomas.
    Ducray F; Mokhtari K; Crinière E; Idbaih A; Marie Y; Dehais C; Paris S; Carpentier C; Dieme MJ; Adam C; Hoang-Xuan K; Duyckaerts C; Delattre JY; Sanson M
    Eur J Cancer; 2011 Mar; 47(5):802-8. PubMed ID: 21194923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotyping low-grade gliomas among Hispanics.
    Cardona AF; Rojas L; Wills B; Behaine J; Jiménez E; Hakim F; Useche N; Bermúdez S; Arrieta O; Mejía JA; Ramón JF; Carranza H; Vargas C; Otero J; González D; Rodríguez J; Ortiz LD; Cifuentes H; Balaña C
    Neurooncol Pract; 2016 Sep; 3(3):164-172. PubMed ID: 31386063
    [TBL] [Abstract][Full Text] [Related]  

  • 8. alpha-Internexin expression identifies 1p19q codeleted gliomas.
    Ducray F; Crinière E; Idbaih A; Mokhtari K; Marie Y; Paris S; Navarro S; Laigle-Donadey F; Dehais C; Thillet J; Hoang-Xuan K; Delattre JY; Sanson M
    Neurology; 2009 Jan; 72(2):156-61. PubMed ID: 19139367
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Machine learning reveals multimodal MRI patterns predictive of isocitrate dehydrogenase and 1p/19q status in diffuse low- and high-grade gliomas.
    Zhou H; Chang K; Bai HX; Xiao B; Su C; Bi WL; Zhang PJ; Senders JT; Vallières M; Kavouridis VK; Boaro A; Arnaout O; Yang L; Huang RY
    J Neurooncol; 2019 Apr; 142(2):299-307. PubMed ID: 30661193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systematically characterize the clinical and biological significances of 1p19q genes in 1p/19q non-codeletion glioma.
    Chai RC; Zhang KN; Chang YZ; Wu F; Liu YQ; Zhao Z; Wang KY; Chang YH; Jiang T; Wang YZ
    Carcinogenesis; 2019 Oct; 40(10):1229-1239. PubMed ID: 31157866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers.
    Figarella-Branger D; Maues de Paula A; Colin C; Bouvier C
    Rev Neurol (Paris); 2011 Oct; 167(10):683-90. PubMed ID: 21889777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IDH mutation and 1p19q codeletion distinguish two radiological patterns of diffuse low-grade gliomas.
    Darlix A; Deverdun J; Menjot de Champfleur N; Castan F; Zouaoui S; Rigau V; Fabbro M; Yordanova Y; Le Bars E; Bauchet L; Gozé C; Duffau H
    J Neurooncol; 2017 May; 133(1):37-45. PubMed ID: 28434111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced expression of DNA repair genes and chemosensitivity in 1p19q codeleted lower-grade gliomas.
    Tang L; Deng L; Bai HX; Sun J; Neale N; Wu J; Wang Y; Chang K; Huang RY; Zhang PJ; Li X; Xiao B; Cao Y; Tao Y; Yang L
    J Neurooncol; 2018 Sep; 139(3):563-571. PubMed ID: 29923053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Erratum to: Prognostic value of
    Neurooncol Adv; 2022; 4(1):vdac069. PubMed ID: 35669014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive Determination of
    Bhandari AP; Liong R; Koppen J; Murthy SV; Lasocki A
    AJNR Am J Neuroradiol; 2021 Jan; 42(1):94-101. PubMed ID: 33243896
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The clinical relevance of 1p19q codeletion of oligodendrogliomas at the Department of Neurosurgery in Debrecen].
    Klekner A; Fekete G; Rencsi M; Méhes G; Szabó P; Bognár L
    Ideggyogy Sz; 2012 Jan; 65(1-2):17-24. PubMed ID: 22338842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IDH mutation, 1p19q codeletion and ATRX loss in WHO grade II gliomas.
    Leeper HE; Caron AA; Decker PA; Jenkins RB; Lachance DH; Giannini C
    Oncotarget; 2015 Oct; 6(30):30295-305. PubMed ID: 26210286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical ATRX expression is not a surrogate for 1p19q codeletion.
    Yamamichi A; Ohka F; Aoki K; Suzuki H; Kato A; Hirano M; Motomura K; Tanahashi K; Chalise L; Maeda S; Wakabayashi T; Kato Y; Natsume A
    Brain Tumor Pathol; 2018 Apr; 35(2):106-113. PubMed ID: 29550880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinicopathologic features of pediatric oligodendrogliomas: a series of 50 patients.
    Rodriguez FJ; Tihan T; Lin D; McDonald W; Nigro J; Feuerstein B; Jackson S; Cohen K; Burger PC
    Am J Surg Pathol; 2014 Aug; 38(8):1058-70. PubMed ID: 24805856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erratum: This is a corrigendum to: Kumthekar et al, A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma, Neuro-Oncology Advances, Volume 4, Issue 1, January-December 2022, vdac123, https://doi.org/10.1093/noajnl/vdac123.
    Neurooncol Adv; 2023; 5(1):vdad103. PubMed ID: 37664526
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.